Tau protein: A potential biological indicator for early recognition of Alzheimer's disease;Tau-protein: Ein potentieller biologischer Indikator zur Fruherkennung der Alzheimer-Krankheit

Nervenarzt

Volumn 69, Issue 5, 1998, Pages 379-385

  Buch, Katharina ^a,d   Riemenschneider, M ^b   Bartenstein, P ^a   Willoch, F ^a   Muller U ^c   Schmolke, M ^b   Nolde, T ^d   Steinmann, C ^a   Guder, W G ^b   Kurz, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b KLINIKUM BOGENHAUSEN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atzheimer's disease; Cerebrospinal fluid; Early recognition; Protein tau

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; NERVE DEGENERATION; PROTEIN DETERMINATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TAU PROTEINS;

EID: 7144259728     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050286     Document Type: Review

References (24)

1. American-Psychiatric-Association (1994) Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. DSM-IV. American Psychiatric Association, Washington
2. Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Machida N, Seiki H, Takase S, Clark CM, Lee VMY et al (1995) Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol 38:649-652
3. Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mösch D, Schad D, Schwaiger M, Kurz A (1997) Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by single-photon emission computed tomography. J Nucl Med 38:1095-1101
4. Del-D-Alonso A, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangels of filaments and dissasembles microtubules. Nature Med 2:783-787
5. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
6. Galasko D, Motter R, Seubert P (1996) Interpreting cerebrospinal fluid tau levels in Alzheimer's disease. Neurobiol Aging 17:1
7. Galasko D,Clark C,Chang L,Miller B,Green RC, Motter R, Seubert P (1997) Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 48:632-635
8. Golombowski S, Muller-Spahn F, Naser W, Hock C (1996) increased levels of tau protein in cerebrospinal fluid of patients with Afzheimer's disease - correlation with degree of cognitive impairment and dependence on apoE4 allele frequency. Neurobiol Aging 17:165-166
9. Hock C, Golombowski S, Naser W, Muller-Spahn F (1995) Increased levels of t protein in cerebrospinal fluid of patients with Alzheimer's disease - correlation with degree of cognitive impairment. Ann Neurol 37:414-415
10. Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB, Müller U (1996) Apolipoprotein E e4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 47:440-443
11. McKhann G, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944
12. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer's disase using three-dimensional stereo tactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238-1248
13. Molina L, Touchon J, Lefranc D, Vermersch P, Pau B, Mourton-Gilles C (1996) Detection of tau proteins in cerebrospinal fluids from Alzheimer's patients. Neurobiol Aging 17:166
14. Ohm TG, Muller H, Braak H, Bohl J (1995) Closemeshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 164:209-217
15. Riemenschneider M, Buch K, Schmolke M, Kurz A, Guder WG (1996) Cerebrospinal protein tau is elevated in early Alzheimer's disease. Neurosci Lett 212:209-211
16. Rösler N, Wichart I, Bancher C, Jellinger KA (1996) Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia? J Neurol Transm 47:259-266
17. Rossor MN, Kennedy AM, Frackowiack RSJ (1996) Clinical and neuroimaging features of familial Alzheimer's disease. Ann NY Acad Sci 777:49-56
18. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H,Verma S, Goddard R (1986) CAMDEX. A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698-709
19. SPSS-Inc (1990) SPSS for the Macintosh: operations guide. SPSS, Chicago
20. Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, New York
21. Tato RA, Frank A, Hemanz A (1995) Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimertype. J Neurol Neurosurg Psychiatry 59:280-283
22. Tierney MC, Fischer RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Niewstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 138:359-364
23. Vigo-Pelfrey C, Seubert P, Blomquist C, Barbour R, Lee M, Lee D, Coria F, Chang L, Miller B, Lieberburg I et al (1995) Tau in cerebrospinal fluid: an antemortem marker for Alzheimer's disease? In: Iqbal K, JA Mortimer, B Winblad, HM Wisniewski (eds) Research advances in Alzheimer's disease and related disorders. Wiley, Chichester, pp 197-205
24. Wenham PR, Price WH, Blundell G (1991) Apolipoprotein E genotyping by onestage PCR. Lancet 337:1158-1159